The latter possibility is likely, because lipoprotein lipase, a serum enzyme responsible for triglyceride degradation, is decreased by inflammation20, which indeed was more severe in AHF patients with worsening of CHF than in de novo AHF patients. This evidence concerns the gene LPL and congestive heart failure.